Immune Booster 28: Immunometabolism, Inflammation, and Building Biotechs with Luke O'Neill

Immunologist Luke O'Neill, professor and chair of biochemistry at Trinity College Dublin, traces his career from early work on cytokine signaling and NF-kappa-B to groundbreaking research in immunometabolism. His work highlights the critical role of metabolic pathways, such as itaconate production, in regulating inflammatory responses. O'Neill emphasizes the importance of rigorous scientific inquiry and the potential of targeting molecules like GDF-15 to treat chronic conditions including obesity and cancer cachexia. Beyond the lab, he advocates for active science communication to counter misinformation and empower patients, viewing the scientific community as a collaborative force for global progress. His experience in translating academic discoveries into clinical trials for NLRP3 inhibitors underscores the long-term impact of fundamental research on therapeutic development, even when navigating the high failure rates inherent in drug discovery.